Isaacs JT - Search Results

1

Preclinical and clinical studies with the multi-kinase inhibitor CEP-701 as treatment for prostate cancer demonstrate the inadequacy of PSA response as a primary endpoint.

Collins C, Carducci MA, Eisenberger MA, Isaacs JT, Partin AW, Pili R, Sinibaldi VJ, Walczak JS, Denmeade SR. Collins C, et al. Among authors: isaacs jt. Cancer Biol Ther. 2007 Sep;6(9):1360-7. doi: 10.4161/cbt.6.9.4541. Epub 2007 Jun 5. Cancer Biol Ther. 2007. PMID: 17786033 Free PMC article.

2

The antitumor effects of the quinoline-3-carboxamide linomide on Dunning R-3327 rat prostatic cancers.

Ichikawa T, Lamb JC, Christensson PI, Hartley-Asp B, Isaacs JT. Ichikawa T, et al. Among authors: isaacs jt. Cancer Res. 1992 Jun 1;52(11):3022-8. Cancer Res. 1992. PMID: 1591718

3

Response of rat and human prostatic cancers to the novel 5 alpha-reductase inhibitor, SK&F 105657.

Lamb JC, Levy MA, Johnson RK, Isaacs JT. Lamb JC, et al. Among authors: isaacs jt. Prostate. 1992;21(1):15-34. doi: 10.1002/pros.2990210103. Prostate. 1992. PMID: 1641369

4

Genetic factors and suppression of metastatic ability of prostatic cancer.

Ichikawa T, Ichikawa Y, Isaacs JT. Ichikawa T, et al. Among authors: isaacs jt. Cancer Res. 1991 Jul 15;51(14):3788-92. Cancer Res. 1991. PMID: 2065333

5

New approaches to the evaluation of the metastatic ability of renal cancer and new approaches to chemotherapy.

Isaacs WB, Isaacs JT, Kyprianou N, Burgers JK, Alexander RB, Partin AW, Mohler JL, Marshall FF, Coffey DS. Isaacs WB, et al. Among authors: isaacs jt. Eur Urol. 1990;18 Suppl 2:33-5. doi: 10.1159/000463958. Eur Urol. 1990. PMID: 2226604 Review. No abstract available.

6

Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation.

Kyprianou N, English HF, Isaacs JT. Kyprianou N, et al. Among authors: isaacs jt. Cancer Res. 1990 Jun 15;50(12):3748-53. Cancer Res. 1990. PMID: 2340521

7

Early cell motility changes associated with an increase in metastatic ability in rat prostatic cancer cells transfected with the v-Harvey-ras oncogene.

Partin AW, Isaacs JT, Treiger B, Coffey DS. Partin AW, et al. Among authors: isaacs jt. Cancer Res. 1988 Nov 1;48(21):6050-3. Cancer Res. 1988. PMID: 3048653

8

Metastatic potential prediction by a visual grading system of cell motility: prospective validation in the Dunning R-3327 prostatic adenocarcinoma model.

Mohler JL, Partin AW, Isaacs JT, Coffey DS. Mohler JL, et al. Among authors: isaacs jt. Cancer Res. 1988 Aug 1;48(15):4312-7. Cancer Res. 1988. PMID: 3390827

9

Human prostatic cancer cells are sensitive to programmed (apoptotic) death induced by the antiangiogenic agent linomide.

Vukanovic J, Isaacs JT. Vukanovic J, et al. Among authors: isaacs jt. Cancer Res. 1995 Aug 15;55(16):3517-20. Cancer Res. 1995. PMID: 7543015

10

The role of calcium, pH, and cell proliferation in the programmed (apoptotic) death of androgen-independent prostatic cancer cells induced by thapsigargin.

Furuya Y, Lundmo P, Short AD, Gill DL, Isaacs JT. Furuya Y, et al. Among authors: isaacs jt. Cancer Res. 1994 Dec 1;54(23):6167-75. Cancer Res. 1994. PMID: 7954463

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

372 results

Search Page

Filters